Posard Matthew L. Insider Trades & Stock Holdings

Director · Halozyme Therapeutics, Inc. · Latest filing Oct 1, 2026

Posard Matthew L., Director at Halozyme Therapeutics, Inc. has 1 Form 4 trade on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($567.66K), net -$567.66K. Latest filing: disposed of 5.23K shares of $HALO on Oct 1, 2026 at $108.54.

Trades on file

1

Open-market bought

$0

Open-market sold

$567.66K

Net open-market

-$567.66K

Latest filing

Oct 1, 2026

All insider trades by Posard Matthew L.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 1, 2026	$HALO	Sell (Open-market sale) 10b5-1	5.23K	$108.54	$567.66K			+2.7%			Director		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Posard Matthew L. traded

• $HALO

Frequently asked questions

Has Posard Matthew L. been buying or selling stock?

Posard Matthew L. has 0 open-market purchases and 1 open-market sale on file, net -$567.66K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Posard Matthew L.'s latest insider trade?

disposed of 5.23K shares of $HALO on Oct 1, 2026 at $108.54.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.